{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:04:48Z","timestamp":1790114688046,"version":"4.0.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.aohep.2026.102241","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T23:39:29Z","timestamp":1781566769000},"page":"102241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Stem cell therapies for liver cirrhosis: a GRADE evaluation through a systematic review"],"prefix":"10.1016","volume":"31","author":[{"given":"Manya","family":"Prasad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Shenoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6559-6867","authenticated-orcid":false,"given":"Tushar","family":"Prabhakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9459-1192","authenticated-orcid":false,"given":"Sunanda","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surbhi","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumridhi","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2322-2864","authenticated-orcid":false,"given":"Vinamrata Kapoor","family":"Ghai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6232-4463","authenticated-orcid":false,"given":"Saraa Angel","family":"L","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keerthi","family":"Keerthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0637-3969","authenticated-orcid":false,"given":"Saumya","family":"Vats","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0412-3431","authenticated-orcid":false,"given":"Farheen","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharat Bhushan","family":"Rewari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.aohep.2026.102241_bib0001","doi-asserted-by":"crossref","first-page":"359","DOI":"10.31083\/j.fbl2812359","article-title":"Stem cell therapy for liver diseases: current perspectives","volume":"28","author":"Wang","year":"2023","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"6","key":"10.1016\/j.aohep.2026.102241_bib0002","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.stemcr.2021.05.004","article-title":"Unproven stem cell interventions: a global public health problem requiring global deliberation","volume":"16","author":"Master","year":"2021","journal-title":"Stem Cell Reports"},{"issue":"3","key":"10.1016\/j.aohep.2026.102241_bib0003","doi-asserted-by":"crossref","first-page":"A12","DOI":"10.7326\/ACPJC-1995-123-3-A12","article-title":"The well-built clinical question: a key to evidence-based decisions","volume":"123","author":"Richardson","year":"1995","journal-title":"ACP J Club"},{"key":"10.1016\/j.aohep.2026.102241_bib0004","series-title":"Cochrane handbook for systematic reviews of interventions","year":"2022"},{"key":"10.1016\/j.aohep.2026.102241_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.aohep.2026.102241_bib0006","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"7650","key":"10.1016\/j.aohep.2026.102241_bib0007","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.aohep.2026.102241_bib0008","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1097\/MEG.0b013e3283488b00","article-title":"Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells","volume":"23","author":"Amer","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.aohep.2026.102241_bib0009","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1111\/ajt.16468","article-title":"Third-party bone marrow-derived mesenchymal stromal cell infusion before liver transplantation: a randomized controlled trial","volume":"21","author":"Casiraghi","year":"2021","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.aohep.2026.102241_bib0010","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1007\/s12015-011-9322-y","article-title":"Phase II trial: undifferentiated versus differentiated autologous mesenchymal stem cells transplantation in Egyptian patients with HCV induced liver cirrhosis","volume":"8","author":"El-Ansary","year":"2012","journal-title":"Stem Cell Rev Rep"},{"issue":"3","key":"10.1016\/j.aohep.2026.102241_bib0011","first-page":"268","article-title":"Autologous bone marrow stem cell transplantation in liver cirrhosis after correcting nutritional anomalies, a controlled clinical study","volume":"21","author":"Esmaeilzadeh","year":"2019","journal-title":"Cell J"},{"issue":"1","key":"10.1016\/j.aohep.2026.102241_bib0012","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/MEG.0b013e32832eb69a","article-title":"Infusion of autologous bone marrow mononuclear cells through hepatic artery results in a short-term improvement of liver function in patients with chronic liver disease: a pilot randomized controlled study","volume":"22","author":"Lyra","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.aohep.2026.102241_bib0013","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1111\/liv.12228","article-title":"Randomized placebo-controlled trial of mesenchymal stem cell transplantation in decompensated cirrhosis","volume":"33","author":"Mohamadnejad","year":"2013","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.aohep.2026.102241_bib0014","doi-asserted-by":"crossref","first-page":"87","DOI":"10.5966\/sctm.2015-0004","article-title":"Intraportal infusion of bone marrow mononuclear or CD133+ cells in patients with decompensated cirrhosis: a double-blind randomized controlled trial","volume":"5","author":"Mohamadnejad","year":"2016","journal-title":"Stem Cell Transl Med"},{"key":"10.1016\/j.aohep.2026.102241_bib0015","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/3662776","article-title":"Bone marrow mesenchymal stem cells in acute-on-chronic liver failure grades 2 and 3: a phase I-II randomized clinical trial","volume":"2021","author":"Schacher","year":"2021","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.aohep.2026.102241_bib0016","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s12072-021-10199-2","article-title":"Mesenchymal stem cell therapy in decompensated liver cirrhosis: a long-term follow-up analysis of the randomized controlled clinical trial","volume":"15","author":"Shi","year":"2021","journal-title":"Hepatol Int"},{"issue":"10","key":"10.1016\/j.aohep.2026.102241_bib0017","doi-asserted-by":"crossref","first-page":"725","DOI":"10.5966\/sctm.2012-0034","article-title":"Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients","volume":"1","author":"Shi","year":"2012","journal-title":"Stem Cell Transl Med"},{"issue":"6","key":"10.1016\/j.aohep.2026.102241_bib0018","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1002\/hep.28693","article-title":"Transplantation with autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: phase 2 trial","volume":"64","author":"Suk","year":"2016","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.aohep.2026.102241_bib0019","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1111\/jgh.12653","article-title":"Randomized trial of autologous bone marrow mesenchymal stem cells transplantation for hepatitis B virus cirrhosis: regulation of treg\/Th17 cells","volume":"29","author":"Xu","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2026.102241_bib0020","first-page":"1","article-title":"Combination treatments of plasma exchange and umbilical cord-derived mesenchymal stem cell transplantation for patients with Hepatitis B virus-related acute-on-chronic liver failure: a clinical trial in China","volume":"2019","author":"Xu","year":"2019","journal-title":"Stem Cell Int"},{"issue":"4","key":"10.1016\/j.aohep.2026.102241_bib0021","doi-asserted-by":"crossref","first-page":"9336","DOI":"10.4238\/2014.February.21.13","article-title":"Curative effect of combined lamivudine, adefovir dipivoxil, and stem cell transplantation on decompensated hepatitis B cirrhosis","volume":"13","author":"Liu","year":"2014","journal-title":"Genet Mol Res"},{"issue":"1","key":"10.1016\/j.aohep.2026.102241_bib0022","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S2468-1253(17)30326-6","article-title":"Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial","volume":"3","author":"Newsome","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"42","key":"10.1016\/j.aohep.2026.102241_bib0023","doi-asserted-by":"crossref","first-page":"5297","DOI":"10.3748\/wjg.v16.i42.5297","article-title":"Autologous CD34+ and CD133+ stem cells transplantation in patients with end stage liver disease","volume":"16","author":"Salama","year":"2010","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.aohep.2026.102241_bib0024","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/scrt459","article-title":"Peripheral vein infusion of autologous mesenchymal stem cells in Egyptian HCV-positive patients with end-stage liver disease","volume":"5","author":"Salama","year":"2014","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"10.1016\/j.aohep.2026.102241_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053719","article-title":"Autologous bone marrow mononuclear cell transplantation in patients with decompensated alcoholic liver disease: a randomized controlled trial","volume":"8","author":"Spahr","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.aohep.2026.102241_bib0026","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3904\/kjim.2015.267","article-title":"Ultrasound-guided percutaneous portal transplantation of peripheral blood monocytes in patients with liver cirrhosis","volume":"32","author":"Yu","year":"2017","journal-title":"Korea J Intern Med"},{"issue":"1","key":"10.1016\/j.aohep.2026.102241_bib0027","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13287-015-0106-1","article-title":"The impact of repeated autologous infusion of haematopoietic stem cells in patients with liver insufficiency","volume":"6","author":"Zekri","year":"2015","journal-title":"Stem Cell Res Ther"},{"issue":"11","key":"10.1016\/j.aohep.2026.102241_bib0028","doi-asserted-by":"crossref","first-page":"e9728","DOI":"10.1590\/1414-431x20209728","article-title":"A novel stem cell therapy for hepatitis B virus-related acute-on-chronic liver failure","volume":"53","author":"Zhu","year":"2020","journal-title":"Braz J Med Biol Res"},{"issue":"4","key":"10.1016\/j.aohep.2026.102241_bib0029","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1080\/14653240802129901","article-title":"Controlled trials in hepatitis B virus-related decompensate liver cirrhosis: peripheral blood monocyte transplant versus granulocyte-colony-stimulating factor mobilization therapy","volume":"10","author":"Han","year":"2008","journal-title":"Cytotherapy"},{"key":"10.1016\/j.aohep.2026.102241_bib0030","article-title":"A comprehensive meta-analysis of stem cell therapy for liver failure: assessing treatment efficacy and modality","volume":"30","author":"Lin","year":"2025","journal-title":"Ann Hepatol"},{"issue":"1","key":"10.1016\/j.aohep.2026.102241_bib0031","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12967-018-1464-0","article-title":"Clinical performance of stem cell therapy in patients with acute-on-chronic liver failure: a systematic review and meta-analysis","volume":"16","author":"Xue","year":"2018","journal-title":"J Transl Med"},{"issue":"1","key":"10.1016\/j.aohep.2026.102241_bib0032","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/s13287-020-01935-w","article-title":"Therapeutic effect and safety of stem cell therapy for chronic liver disease: a systematic review and meta-analysis of randomized controlled trials","volume":"11","author":"Zhou","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.aohep.2026.102241_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinepi.2023.11.001","article-title":"Compelling evidence from meta-epidemiological studies demonstrates overestimation of effects in randomized trials that fail to optimize randomization and blind patients and outcome assessors","volume":"165","author":"Wang","year":"2024","journal-title":"J Clin Epidemiol"},{"issue":"12","key":"10.1016\/j.aohep.2026.102241_bib0034","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1001\/jama.2010.310","article-title":"Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis","volume":"303","author":"Bassler","year":"2010","journal-title":"JAMA"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S166526812600061X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S166526812600061X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:23:24Z","timestamp":1790112204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S166526812600061X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S166526812600061X"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2026.102241","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stem cell therapies for liver cirrhosis: a GRADE evaluation through a systematic review","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2026.102241","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"102241"}}